| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXHL2500125 | TAR-210 | erdafitinib | Active ingredient | Chemical Drugs(2.2;2.4) | Import Drug Application | 2025-06-06 | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | view | |||
| JXHL2400065 | TAR-210 | erdafitinib | Active ingredient | Chemical Drugs(2.2;2.4) | Import Drug Application | 2024-03-15 | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | view |